Docoh
Loading...

TMDI Titan Medical

Titan Medical Inc. is focused on robotic-assisted technologies for application in minimally invasive surgery (“MIS”). Enos, by Titan Medical, is being developed to become the new standard of care in robotic single access surgery, and comprises a surgeon-controlled patient cart that includes a dual-view camera system with 3D and 2D high-definition vision systems and multi-articulating instruments for performing MIS procedures, and a surgeon workstation that provides an ergonomic interface to the MIS procedure performed through the patient cart. With the Enos system, Titan intends to initially pursue gynecologic surgical indications.

Company profile

TMDI stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

31 Mar 21
27 Jul 21
31 Dec 21
Quarter (USD)
Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

2.5% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 49 44 +11.4%
Opened positions 12 8 +50.0%
Closed positions 7 5 +40.0%
Increased positions 17 10 +70.0%
Reduced positions 6 9 -33.3%
13F shares
Current Prev Q Change
Total value 4.81M 42.52M -88.7%
Total shares 2.76M 3.25M -15.0%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Renaissance Technologies 1.09M $1.85M +85.0%
Two Sigma Advisers 185.9K $316K -23.0%
BAC Bank Of America 179.24K $304K +89.0%
Cito Capital 159K $270K NEW
MS Morgan Stanley 123.83K $211K -18.7%
COF Capital One Financial 100K $170K 0.0%
JPM JPMorgan Chase & Co. 77.5K $132K +14.8%
Accredited Investors 73.83K $126K NEW
Stratos Wealth Partners 71.85K $122K +38.6%
Creative Planning 69.91K $119K NEW
Largest transactions
Shares Bought/sold Change
Masters Capital Management 0 -1.25M EXIT
Renaissance Technologies 1.09M +500.78K +85.0%
Armistice Capital 0 -278.79K EXIT
Cito Capital 159K +159K NEW
BAC Bank Of America 179.24K +84.41K +89.0%
Accredited Investors 73.83K +73.83K NEW
Creative Planning 69.91K +69.91K NEW
Two Sigma Advisers 185.9K -55.6K -23.0%
DB Deutsche Bank AG - Registered Shares 51.8K +51.8K NEW
Advisor 66.24K +51.8K +358.9%

Financial report summary

?
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg

Proxies

No filings